The article offers guidelines on how to administer Tissue Plasminogen Activator (TPA) to an adult suffering from acute ischemic stroke in the U.S. It states that patient and family must be informed about the intracere...
Owing to its high disability and mortality rates, stroke has been the second leading cause of death worldwide. Since the pathological mechanisms of stroke are not fully understood, there are few clinical treatment strategies available with an exception of tissue plasminogen activator (tPA), the only...
Ischemic stroke is an acute neurological condition caused by impaired cerebral blood flow (e.g., vascular occlusion or systemic hypoperfusion). The most important risk factors are chronic systemic ...
et al. Chinese acute ischemic stroke treatment outcome registry (CASTOR): protocol for a prospective registry study on patterns of real-world treatment of acute ischemic stroke in China. BMC Complement Altern Med 17, 357 (2017). https://doi.org/10.1186/s12906-017-1863-4 Download citation ...
Abstract DP3: Thrombolysis for Ischemic Stroke after 4.5 hours without thrombectomy: A Meta-analysis of Randomized Controlled Trials doi:10.1161/str.56.suppl_1.DP3Ischemia reperfusionStrokeThrombolysisTissue plasminogen activator (tPA)Background:Current guidelines for ischemic stroke recommend initiating ...
We induced MSCs into neurogenesis using a modified protocol. The therapeutic potency of the resulting neural progenitor cells in a rat model of ischemic stroke was analyzed. Using a highly hydrophobic diphenylamino-s-triazine-bridged p-phenylene (DTOPV)-coated surface and adopting a procedure for ...
IV tPA for Acute Ischemic Stroke: Results of the First 101 Patients in a Community PracticeDick, Arthur P. MD; Straka, Janet MSN, APRN, BC Abstract Background: Reviews of the use of intravenous tissue type plasminogen activator (IV tPA) for acute stroke in community hospitals have raised ...
et al. Solitaire™ with the intention for thrombectomy as primary endovascular treatment for acute ischemic stroke (swift prime) trial: protocol for a randomized, controlled, multicenter study comparing the solitaire revascularization device with iv tpa with iv tpa alone in acute ischemic stroke. ...
You might be interested in... Partner Content Calculated Decisions: tPA Dosing Emergency Medicine Practice Content Contributors Bryan D. Hayes, PharmD
et al. Solitaire™ with the intention for thrombectomy as primary endovascular treatment for acute ischemic stroke (swift prime) trial: protocol for a randomized, controlled, multicenter study comparing the solitaire revascularization device with iv tpa with iv tpa alone in acute ischemic stroke. ...